文献速递乳房整形与再造显微修复重建

医院年总出院量与非游离皮瓣乳房再造围手术期结局的关联

The Association of Overall Annual Hospital Volume and Perioperative Outcomes following Free Flap Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2021-01-01

该研究利用美国全国住院患者样本数据库,纳入7991例游离皮瓣乳房再造患者,分析医院年总出院量与围手术期并发症的关系。限制性立方样条提示可能的阈值出院量,但患者层面分析显示低容量与高容量医院在全身并发症(OR 1.28,95%CI 0.75-2.18,p=0.36)和显微外科并发症(OR 1.06,95%CI 0.78-1.44,p=0.73)风险上无差异。结论认为医院总年出院量不应作为高质量乳房游离皮瓣护理的替代指标。

要点

  • 低容量与高容量医院游离皮瓣乳房再造的围手术期全身及显微外科并发症风险无显著差异。
  • 医院年总出院量不应作为高质量乳房游离皮瓣护理的替代指标。
  • 患者结局更可能与外科医生及项目团队经验相关。

核心结论

  • 游离皮瓣乳房再造的围手术期并发症在低容量与高容量医院之间无差异,医院总年出院量不应作为高质量护理的替代指标。

研究设计与样本

  • 利用美国医疗成本与利用项目全国住院患者样本数据库,识别1907家中心的7991例游离皮瓣乳房再造患者。
  • 采用逻辑回归分析医院年总出院量与全身、手术及显微外科并发症的关联,并根据阈值容量将患者分为低容量与高容量医院组。

主要发现

  • 限制性立方样条提示全身并发症和显微外科并发症风险可能变化的阈值出院量分别为13018(95%CI 7468-14512)和7091(95%CI 5396-9918)例/年。
  • 患者层面分析显示,低容量与高容量医院在全身并发症(OR 1.28;95%CI 0.75-2.18;p=0.36)和显微外科并发症(OR 1.06;95%CI 0.78-1.44;p=0.73)风险上无显著差异。

临床怎么用

  • 评估乳房游离皮瓣再造质量时,不应仅依据医院年总出院量,应关注外科医生及团队经验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hospital volume has been correlated with improved outcomes in oncologic care and complex surgical procedures. The authors sought to determine the relationship between overall annual hospital volume and perioperative outcomes following free flap breast reconstruction. METHODS: Free flap breast reconstruction patients (n = 7991) were identified at 1907 centers using the Healthcare Cost and Utilization Project National Inpatient Sample database. Logistic regression characterized the association of hospital volume (total discharges per year) with systemic, surgical, and microsurgical complications. Patients were categorized as being treated at low- versus high-volume hospitals based on identified threshold volumes, and the association with the incidence of complications was estimated. RESULTS: Initially, restricted cubic spline analysis suggested potential threshold volumes of 13,018 (95 percent CI, 7468 to 14,512) and 7091 (95 percent CI, 5396 to 9918) discharges per year, at which the risk for developing systemic and microsurgical complications may change, respectively. However, further patient-level evaluation of treatment at low- versus high-volume hospitals demonstrated that hospital volume did not predict the risk of developing perioperative systemic (OR, 1.28; 95 percent CI, 0.75 to 2.18; p = 0.36) or microsurgical complications (OR, 1.06; 95 percent CI, 0.78 to 1.44; p = 0.73). CONCLUSIONS: Perioperative complications after free flap breast reconstruction did not differ between patients treated at low- versus high-volume hospitals after in-depth multiprong analysis. Patient outcomes are more likely associated with surgeon and programmatic experience. Overall annual hospital volume should not serve as a proxy for high-quality breast free flap care. . CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Shammas RL, Ren Y, Thomas SM, et al. The Association of Overall Annual Hospital Volume and Perioperative Outcomes following Free Flap Breast Reconstruction. Plast Reconstr Surg. 2021. PMID: 33565821. doi:10.1097/PRS.0000000000007549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。